Olink

Olink®
Part of Thermo Fisher Scientific

Scientific publications

Discover the latest research using Olink’s panels for protein biomarker discovery through our comprehensive list of publications. Easily find relevant studies by filtering them or using the free-text search.  Access abstracts, PubMed entries, and full-text papers directly through the links provided.

Filter

Filters

Publication
Disease Area
Application Area
Sample Type
Products

GeroScience, 2023

Exploring the possible causal effects of cardiac blood biomarkers in dementia and cognitive performance: a Mendelian randomization study

Zonneveld M., Trompet S., Jukema J. et al.

Microorganisms, 2023

Systemic Inflammatory Molecules Are Associated with Advanced Fibrosis in Patients from Brazil Infected with Hepatitis Delta Virus Genotype 3 (HDV-3)

Souza Campos M., Villalobos-Salcedo J., Vieira Dallacqua D. et al.

Neurobiology of Disease, 2023

Uncovering a neurological protein signature for severe COVID-19

El-Agnaf O., Bensmail I., Al-Nesf M. et al.

BMC Medicine, 2023

Chemotherapy-induced weight gain in early-stage breast cancer: a prospective matched cohort study reveals associations with inflammation and gut dysbiosis

Walker J., Joy A., Vos L. et al.

Clinical Rheumatology, 2023

Plasma proteomic profiling reveals KRT19 could be a potential biomarker in patients with anti-MDA5+ dermatomyositis

Zhang P., Li M., Zhang Y. et al.

International Journal of Molecular Sciences, 2023

Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers for Multiple Myeloma: A Meta-Analysis of Three Large Cohorts and Functional Characterization

Clavero E., Sanchez-Maldonado J., Macauda A. et al.

Journal of Clinical Immunology, 2023

Insights into the expanding intestinal phenotypic spectrum of SOCS1 haploinsufficiency and therapeutic options

Rodari M., Cazals-Hatem D., Uzzan M. et al.

The American Journal of Human Genetics, 2023

Genome-wide aggregated trans-effects on risk of type 1 diabetes: A test of the “omnigenic” sparse effector hypothesis of complex trait genetics

Iakovliev A., McGurnaghan S., Hayward C. et al.

Frontiers in Immunology, 2023

Type 1 interferon signature in peripheral blood mononuclear cells and monocytes of idiopathic inflammatory myopathy patients with different myositis-specific autoantibodies

Li M., Zhang Y., Zhang W. et al.

Thrombosis Research, 2023

Unsupervised clustering of venous thromboembolism patients by clinical features at presentation identifies novel endotypes that improve prognostic stratification

Pallares Robles A., ten Cate V., Lenz M. et al.

Stress, 2023

The chronic stress risk phenotype mirrored in the human retina as a neurodegenerative condition

Malan L., van Wyk R., von Känel R. et al.

Scientific Reports, 2023

Age-dependent differences and similarities in the plasma proteomic signature of postoperative delirium

Oren R., Kim E., Leonard A. et al.

Hepatology, 2023

Bile exosomal miR-182/183-5p increases cholangiocarcinoma stemness and progression by targeting HPGD and increasing PGE2 generation

Shu L., Li X., Liu Z. et al.

Brain, Behavior, and Immunity, 2023

Immunological protein profiling of first-episode psychosis patients identifies CSF and blood biomarkers correlating with disease severity

Eren F., Schwieler L., Orhan F. et al.

JACC: Heart Failure, 2023

Myeloperoxidase Inhibition Reverses Biomarker Profiles Associated With Clinical Outcomes in HFpEF

Michaëlsson E., Lund L., Hage C. et al.

Nature Communications, 2023

Identification of biomarkers for glycaemic deterioration in type 2 diabetes

Slieker R., Donnelly L., Akalestou E. et al.

International Journal of Molecular Sciences, 2023

Blood-Based Proteomic Profiling Identifies Potential Biomarker Candidates and Pathogenic Pathways in Dementia

Ehtewish H., Mesleh A., Ponirakis G. et al.

Annals of Hematology, 2023

Switching from imatinib to nilotinib plus pegylated interferon-α2b in chronic phase CML failing to achieve deep molecular response: clinical and immunological effects

Geelen I., Gullaksen S., Ilander M. et al.

Science Advances, 2023

Druggable proteins influencing cardiac structure and function: Implications for heart failure therapies and cancer cardiotoxicity

Schmidt A., Bourfiss M., Alasiri A. et al.

Med, 2023

RNase2 is a possible trigger of acute-on-chronic inflammation leading to mRNA vaccine-associated cardiac complication

Ong E., Koh C., Tng D. et al.

4586 publications